Drugs of Abuse Testing Market by Product and Geography - Forecast and Analysis 2022-2026

Published: Mar 2022

Pages: 120

SKU: IRTNTR72972

Snapshot

The drugs of abuse testing market share is expected to increase by USD 1.24 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.25%.

This drugs of abuse testing market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers drug of abuse testing market segmentation by product (instruments and consumables) and Geography (North America, Europe, Asia, and Rest of World (ROW)). The drugs of abuse testing market report also offer information on several market vendors, including Abbott Laboratories, Bio Rad Laboratories Inc., CareHealth America Corp., Clinical Reference Laboratory Inc., Cordant Health Solutions, Danaher Corp., Dragerwerk AG and Co. KGaA, F. Hoffmann La Roche Ltd., Laboratory Corp. of America Holdings, Omega Laboratories Inc., Ortho-Clinical Diagnostics Inc., Precision Diagnostics, Psychemedics, Quest Diagnostics Inc., Randox Laboratories Ltd., Shimadzu Corp., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Merck KGaA, and SureHire Inc. among others.

What will the Drugs of Abuse Testing Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Drugs of Abuse Testing Market Size for the Forecast Period and Other Important Statistics

Drugs of Abuse Testing Market: Key Drivers, Trends, and Challenges

The increased strategic developments is notably driving the drugs of abuse testing market growth, although factors such as high costs may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the drugs of abuse testing industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Drugs of Abuse Testing Market Driver

One of the key factors driving the global drugs of abuse testing industry growth is the increased strategic developments. The key strategies adopted include the launch of new products, product approvals, joint ventures, acquisitions, partnerships, expansion projects, collaborations, and investments. For instance, Laboratory Corp. of America Holdings (LabCorp) and the Recovery Platform jointly provide access to medication-assisted opioid treatment on a national basis in the US. The Recovery Platform has been designed to aid primary care physicians in addressing and managing the recovery of patients suffering from opioid-use disorders in a compliant and efficient manner. Similarly, Thermo Fisher Scientific provides Ortho-Clinical Diagnostics with assays which can be for monitoring drugs of abuse. Additionally, Danaher offers 6-Acetylmorphine (6-AM) and Buprenorphine (BUP) assays for drugs of abuse tests to onsite testing laboratories. Such factors are expected to support the market growth during the forecast period.

Key Drugs of Abuse Testing Market Trend

Growing adoption of information management solutions is one of the key drugs of abuse testing market trends that is expected to impact the industry positively in the forecast period. The LIMS software systems offer savings on additional costs as they eliminate the need for paper records, and a single LIMS software manages the functioning of the entire drugs of abuse testing laboratory. Vendors such as Analytical 360, CannaSafe Analytics, Cannalysis offer LIMS software programs of their own, which aid drugs of abuse testing laboratories in carrying out the analysis efficiently besides providing greater cost savings. For instance, the software program from Pharmlabs provides a comprehensive overview of the results and also offers correlation tools that are built into the results platform, which the researchers can use multiple times to generate critical analysis. Such factors will further drive market growth throughout the forecast years.

Key Drugs of Abuse Testing Market Challenge

One of the key challenges to the global drugs of abuse testing industry growth is the high costs. Key leading vendors in the market such as Merck, Shimadzu, and Thermo Fisher Scientific offer high-quality analytical products for drugs of abuse testing, but these are all very expensive, which hampers their use by laboratories. An entry-level mass spectrometer, with the most basic settings and possibly with a liquid handling system attached or in-built, costs around USD 100,000. When researchers try to add minute customizations, costs can increase exponentially as multiple parameters need to be changed by the manufacturer to make a compatible product. Thus, smaller laboratories with small budget allocations for instruments may be able to afford to purchase only basic drugs of abuse testing instruments or outsource the entire testing process. This might negatively impact the adoption of drugs of abuse testing products, thus hindering market growth during the forecast period.

This drugs of abuse testing market analysis report also provide detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global drugs of abuse testing market as a part of the global life science tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the drugs of abuse testing market during the forecast period.

Who are the Major Drugs of Abuse Testing Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

This statistical study of the drugs of abuse testing market encompasses successful business strategies deployed by the key vendors. The drugs of abuse testing market is fragmented and the vendors are deploying growth strategies such as the launch of new products and M and A to compete in the market.

Product Insights and News

Abbott Laboratories - The company offers the iScreen Drugs of Abuse Test Card that rapidly screens for a broad range of illicit and prescription drugs.
Abbott Laboratories - Under the established pharmaceuticals products segment, the company manufacturers branded generic pharmaceuticals for established and emerging markets.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The drugs of abuse testing market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Drugs of Abuse Testing Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the drugs of abuse testing market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Drugs of Abuse Testing Market?

For more insights on the market share of various regions Request for a FREE sample now!

37% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for drugs of abuse testing in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).

The significant increase in the demand for drugs of abuse testing owing to the rise in cases of drug abuse will facilitate the drug of abuse testing market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the COVID-19 pandemic had a positive impact on the regional drugs of abuse testing market. The governments of various countries such as the US, Canada, and Mexico imposed nationwide lockdowns to curb the spread of the disease. The use of drugs increased significantly from 2020 to 2021, as users stayed at home and engaged in using illicit drugs. These factors will contribute to the increased usage of drugs of abuse testing products in the region. Thus, the regional drugs of abuse testing market is expected to witness growth during the forecast period.

What are the Revenue-generating Product Segments in the Drugs of Abuse Testing Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The drugs of abuse testing market share growth by the instruments segment will be significant during the forecast period. The availability of a broad range of advanced instruments coupled with continuous innovations, which increase the overall efficiency of the drugs of abuse testing process, are the key factors that will support the growth of this segment during the forecast years.

This report provides an accurate prediction of the contribution of all the segments to the growth of the drugs of abuse testing market size and actionable market insights on post COVID-19 impact on each segment.

Drugs of Abuse Testing Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 5.25%
Market growth 2022-2026	$ 1.24 billion
Market structure	Fragmented
YoY growth (%)	5.15
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 37%
Key consumer countries	US, Canada, Denmark, China, and India
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Abbott Laboratories, Bio Rad Laboratories Inc., CareHealth America Corp., Clinical Reference Laboratory Inc., Cordant Health Solutions, Danaher Corp., Dragerwerk AG and Co. KGaA, F. Hoffmann La Roche Ltd., Laboratory Corp. of America Holdings, Omega Laboratories Inc., Ortho-Clinical Diagnostics Inc., Precision Diagnostics, Psychemedics, Quest Diagnostics Inc., Randox Laboratories Ltd., Shimadzu Corp., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Merck KGaA, and SureHire Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Drugs of Abuse Testing Market Report?

CAGR of the market during the forecast period 2022-2026
Detailed information on factors that will drive drugs of abuse testing market growth during the next five years
Precise estimation of the drugs of abuse testing market size and its contribution to the parent market
Accurate predictions on upcoming trends and changes in consumer behavior
The growth of the drugs of abuse testing industry across North America, Europe, Asia, and Rest of World (ROW)
A thorough analysis of the market's competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of drugs of abuse testing market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 12: Market segments

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between2021 and 2026

4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

5.1 Market segments
- Exhibit 24: Chart on Product - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Product - Market share 2021-2026 (%)

5.2 Comparison by Product
- Exhibit 26: Chart on Comparison by Product
- Exhibit 27: Data Table on Comparison by Product

5.3 Instruments - Market size and forecast 2021-2026
- Exhibit 28: Chart on Instruments - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Instruments - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Instruments - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Instruments - Year-over-year growth 2021-2026 (%)

5.4 Consumables - Market size and forecast 2021-2026
- Exhibit 32: Chart on Consumables - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Consumables - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Consumables - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Consumables - Year-over-year growth 2021-2026 (%)

5.5 Market opportunity by Product
- Exhibit 36: Market opportunity by Product ($ million)

6 Customer Landscape

6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)

7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison

7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)

7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)

7.5 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)

7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

7.7 US - Market size and forecast 2021-2026
- Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)

7.8 Denmark - Market size and forecast 2021-2026
- Exhibit 62: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Denmark - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Denmark - Year-over-year growth 2021-2026 (%)

7.9 China - Market size and forecast 2021-2026
- Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)

7.10 Canada - Market size and forecast 2021-2026
- Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)

7.11 India - Market size and forecast 2021-2026
- Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)

7.12 Market opportunity by geography
- Exhibit 78: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers

8.2 Market challenges

8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026

8.4 Market trends

9 Vendor Landscape

9.1 Overview

9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation

9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption

9.4 Industry risks
- Exhibit 82: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
- Exhibit 83: Vendors covered

10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification

10.3 Abbott Laboratories
- Exhibit 85: Abbott Laboratories - Overview
- Exhibit 86: Abbott Laboratories - Business segments
- Exhibit 87: Abbott Laboratories - Key news
- Exhibit 88: Abbott Laboratories - Key offerings
- Exhibit 89: Abbott Laboratories - Segment focus

10.4 Bio Rad Laboratories Inc.
- Exhibit 90: Bio Rad Laboratories Inc. - Overview
- Exhibit 91: Bio Rad Laboratories Inc. - Business segments
- Exhibit 92: Bio Rad Laboratories Inc. - Key news
- Exhibit 93: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 94: Bio Rad Laboratories Inc. - Segment focus

10.5 Danaher Corp.
- Exhibit 95: Danaher Corp. - Overview
- Exhibit 96: Danaher Corp. - Business segments
- Exhibit 97: Danaher Corp. - Key news
- Exhibit 98: Danaher Corp. - Key offerings
- Exhibit 99: Danaher Corp. - Segment focus

10.6 F. Hoffmann La Roche Ltd.
- Exhibit 100: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 101: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 102: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 103: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 104: F. Hoffmann La Roche Ltd. - Segment focus

10.7 Laboratory Corp. of America Holdings
- Exhibit 105: Laboratory Corp. of America Holdings - Overview
- Exhibit 106: Laboratory Corp. of America Holdings - Business segments
- Exhibit 107: Laboratory Corp. of America Holdings - Key news
- Exhibit 108: Laboratory Corp. of America Holdings - Key offerings
- Exhibit 109: Laboratory Corp. of America Holdings - Segment focus

10.8 Merck KGaA
- Exhibit 110: Merck KGaA - Overview
- Exhibit 111: Merck KGaA - Product / Service
- Exhibit 112: Merck KGaA - Key offerings

10.9 Ortho-Clinical Diagnostics Inc.
- Exhibit 113: Ortho-Clinical Diagnostics Inc. - Overview
- Exhibit 114: Ortho-Clinical Diagnostics Inc. - Business segments
- Exhibit 115: Ortho-Clinical Diagnostics Inc. - Key offerings
- Exhibit 116: Ortho-Clinical Diagnostics Inc. - Segment focus

10.10 Quest Diagnostics Inc.
- Exhibit 117: Quest Diagnostics Inc. - Overview
- Exhibit 118: Quest Diagnostics Inc. - Business segments
- Exhibit 119: Quest Diagnostics Inc. - Key offerings
- Exhibit 120: Quest Diagnostics Inc. - Segment focus

10.11 Siemens Healthineers AG
- Exhibit 121: Siemens Healthineers AG - Overview
- Exhibit 122: Siemens Healthineers AG - Business segments
- Exhibit 123: Siemens Healthineers AG - Key news
- Exhibit 124: Siemens Healthineers AG - Key offerings
- Exhibit 125: Siemens Healthineers AG - Segment focus

10.12 Thermo Fisher Scientific Inc.
- Exhibit 126: Thermo Fisher Scientific Inc. - Overview
- Exhibit 127: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 128: Thermo Fisher Scientific Inc. - Key news
- Exhibit 129: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 130: Thermo Fisher Scientific Inc. - Segment focus

11 Appendix

11.1 Scope of the report

11.2 Inclusions and exclusions checklist
- Exhibit 131: Inclusions checklist
- Exhibit 132: Exclusions checklist

11.3 Currency conversion rates for US$
- Exhibit 133: Currency conversion rates for US$

11.4 Research methodology
- Exhibit 134: Research methodology
- Exhibit 135: Validation techniques employed for market sizing
- Exhibit 136: Information sources

11.5 List of abbreviations
- Exhibit 137: List of abbreviations

growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.

product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

drugs of abuse testing market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis